Cargando…
Clinical efficacy of tigecycline used as monotherapy or in combination regimens for complicated infections with documented involvement of multiresistant bacteria
INTRODUCTION: Tigecycline is an established treatment option for infections with multiresistant bacteria (MRB). It retains activity against many strains with limited susceptibility to other antibiotics. Efficacy and safety of tigecycline as monotherapy or in combination regimens were investigated in...
Autores principales: | Heizmann, W. R., Löschmann, P.-A., Eckmann, C., von Eiff, C., Bodmann, K.-F., Petrik, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315528/ https://www.ncbi.nlm.nih.gov/pubmed/25367409 http://dx.doi.org/10.1007/s15010-014-0691-4 |
Ejemplares similares
-
Treatment of complicated skin and soft-tissue infections caused by resistant bacteria: value of linezolid, tigecycline, daptomycin and vancomycin
por: Eckmann, Christian, et al.
Publicado: (2010) -
Dihydropyrimidinones Against Multiresistant Bacteria
por: Castro Jara, Marisa, et al.
Publicado: (2022) -
Multiresistant bacteria in icu: in the right path
por: Moreno, O, et al.
Publicado: (2015) -
Efficacy of an intravenous colistin regimen in ventilator-associated pneumonia and bacteraemia due to multiresistant Gram-negative bacteria: preliminary results
por: Frantzeskaki, F, et al.
Publicado: (2006) -
Risk factors for colonization and infection by multiresistant bacteria
por: Carvalho Brugger, S, et al.
Publicado: (2015)